UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by North Point Portfolio Managers Corp OH

North Point Portfolio Managers Corp OH cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1.2% in the 4th quarter, Holdings Channel reports. The fund owned 36,444 shares of the healthcare conglomerate’s stock after selling 430 shares during the period. UnitedHealth Group accounts for about 3.5% of North Point Portfolio Managers Corp OH’s investment portfolio, making the stock its 6th biggest position. North Point Portfolio Managers Corp OH’s holdings in UnitedHealth Group were worth $19,187,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Moneta Group Investment Advisors LLC raised its holdings in UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after purchasing an additional 11,812,017 shares in the last quarter. Norges Bank bought a new stake in UnitedHealth Group in the fourth quarter worth $5,210,004,000. Arrowstreet Capital Limited Partnership boosted its holdings in UnitedHealth Group by 1,682.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after acquiring an additional 2,540,538 shares during the period. Barclays PLC lifted its stake in shares of UnitedHealth Group by 143.4% in the second quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock valued at $1,679,401,000 after buying an additional 2,058,829 shares during the period. Finally, Morgan Stanley lifted its stake in shares of UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after buying an additional 1,893,192 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research report on Friday, January 19th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 17th. HSBC reaffirmed a “reduce” rating and issued a $480.00 price objective (down from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Finally, Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $579.33.

Check Out Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Price Performance

UNH stock traded up $3.20 during trading on Wednesday, reaching $461.34. 1,619,871 shares of the company were exchanged, compared to its average volume of 4,160,251. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $554.70. The company has a 50-day moving average of $500.89 and a two-hundred day moving average of $518.93. The company has a market capitalization of $425.32 billion, a price-to-earnings ratio of 19.29, a P/E/G ratio of 1.33 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. During the same period in the prior year, the company posted $5.34 EPS. The company’s revenue was up 14.1% on a year-over-year basis. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.63%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.54%.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is available at this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.